September 2022
-
09.22.2022
Prescription Medicines Medicines Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries
-
09.09.2022
Prescription Medicines Medicines FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata
August 2022
-
08.05.2022
June 2022
-
06.30.2022
Prescription Medicines Medicines Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID™
-
06.14.2022
Prescription Medicines Medicines Pfizer Reports Additional Data on PAXLOVID™ Supporting Upcoming New Drug Application Submission to U.S. FDA
-
06.04.2022
-
06.02.2022
May 2022
-
05.06.2022
April 2022
-
04.27.2022
-
04.12.2022
March 2022
-
03.29.2022
-
03.23.2022